Navigation Links
CV Therapeutics Reports 2007 Third Quarter Financial Results
Date:11/6/2007

with regadenoson and Ranexa.

For the nine months ended September 30, 2007, total costs and expenses were $207.9 million compared to total costs and expenses of $233.0 million for the same period in the prior year. The decrease for the nine months ended September 30, 2007 compared to the same period in the prior year was primarily due to lower research and development expenses resulting from lower clinical trial expenses related to the completion of the MERLIN TIMI-36 study of Ranexa and lower regadenoson research and development expense, lower sales and marketing expenses due to the end of the ACEON(R) co-promotion arrangement and lower Ranexa sales and marketing expenses. These decreases were partially offset by costs associated with the restructuring plan implemented in May 2007, which included severance benefits, stock-based compensation expense related to accelerated vesting of employee stock options and forfeiture of certain stock appreciation rights and costs related to excess leased office space and higher cost of sales due to higher net product sales of Ranexa.

At September 30, 2007, the Company had cash, cash equivalents, marketable securities and restricted cash of $199.5 million compared to $223.7 million at June 30, 2007. Our total cash utilized for the quarter ended September 30, 2007 was $24.2 million. This compares to our cash utilized for the prior quarter of $43.4 million which included $3.3 million in restructuring expenses paid in the quarter, offset by the benefit of the non-recurring collaboration milestone payment of $7.0 million from Astellas Pharma US, Inc. In the second quarter, excluding the impact of these non-recurring items, cash utilized was $47.1 million.

Company management will webcast a conference call on November 6, 2007 at 4:30 p.m. EST, 1:30 p.m. PST, on the Company's website. To access the live webcast, please log on to the Company's website at http://www.cvt.com a
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... one of the most loved online bamboo product suppliers; the ... Recently, it has announced its new selection of bamboo ... to offer one-stop shopping solutions for people who want to ... is providing big discounts for all the brand new bamboo ... discounted price (up to 30% off) before the deadline on ...
(Date:8/27/2014)... 27, 2014 IntelliSoft Group, LLC, a ... software, will unveil IntelliCred, IntelliApp and IntelliContract ... Medical Staff Services (NHAMSS) Annual Conference on September 16, ... Bedford, NH. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection Tab ...
(Date:8/27/2014)... August 27, 2014 President Obama is ... immigration. A White House initiative that supplies green ... undocumented immigrants would also open a pathway to Social ... , Access to work authorization would add new ... the program is the target of proposals to cut ...
(Date:8/27/2014)... August 27, 2014 Janice Holly Booth ... necessity when no-one would join her on an adventure outing ... an extreme sport involving ropes, harnesses and rappelling into mysterious, ... with solo travel but definitely not my last,” she says. ... that pushed me to the edge, and experienced first-hand the ...
(Date:8/27/2014)... 2014 *To find out more about this ... Clinical Research on the web ( http://www.achieveclinical.com ) or contact ... There is no cost to participate ... Compensation may be provided for time and travel ... that there are at least 5 million Americans living with ...
Breaking Medicine News(10 mins):Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3
... in Canadian hospitals, way beyond estimation, raising concern among ... investigator in the study said, “The stark reality in ... and other drug-resistant bacteria are posing a serious threat ... these super bugs are more likely to have longer ...
... a drug charity has revealed that young men are ... looks as well as to boost their self-confidence.// ... body builders and athletes to improve their performance, were ... building site workers between the ages 16 and 25. ...
... been developed by a researcher from Cornell University that detects ... in food processing.// , ‘It’s very inexpensive, it ... and it could be activated for whatever you want to ... Professor of Fibre Science and Apparel Design at Cornell. ...
... next week the distribution of a drug to help fight ... Africa is being affected by an extremely virulent strain of ... in the country. The health officials have now promised that ... next week to help fight the disease. The officials but ...
... properly for their safety and efficacy, says a ... // The drugs that are being indiscriminately prescribed ... ,The researchers analyzed drugs covered by a "congressionally ... the Food and Drug Administration (FDA) may extend ...
... branded inhalation capsules in India for the treatment of ... Beta2-agonist Formoterol and the most potent inhaled corticosteroid Fluticasone, ... 100 mcg, Avessa 250 mcg, Avessa 500 mcg, depending ... product is to be used only with the Rheohaler ...
Cached Medicine News:Health News:Nanotech Wipes for biohazard detection 2Health News:South Africa To Make Available Two New Drugs To Fight The TB Outbreak 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 3
(Date:8/26/2014)... Aug. 26, 2014  When it comes to diabetes supplies, ... relevance. But Timesulin happens to answer a real medical ... pen on the market, Timesulin shows how long it,s ... preventing from missed or double insulin doses. Very easy ... back on the insulin pen after an injection. There ...
(Date:8/26/2014)... 26, 2014 Acelleron Medical Products of ... ., is expanding.  Acelleron, a home medical equipment provider, ... division, Acelleron Maternal Health & Wellness (MHW), to offer a ... full range of resources for pregnant women and families. ... director of maternal wellness. Vecchi, the former owner of Maternal ...
(Date:8/26/2014)... TUCSON, Ariz. , Aug. 26, 2014 ... Artificial Heart, is high on the Inc. 5000 named ... "SynCardia manufactures the world,s only FDA, Health Canada and ... a bridge to a matching donor heart transplant," says ... "It has become the standard of care for patients ...
Breaking Medicine Technology:Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2
... Cumberland Pharmaceuticals Inc. (Nasdaq: ... from the U.S. Food and Drug Administration (FDA) for ... the Company,s product used to treat acetaminophen poisoning. The ... tetracetic acid or any other stabilization and chelating agents ...
... Marshals, acting under a court order sought by the ... 6, seized all dental devices from Rite-Dent Manufacturing Corporation, ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The seizure of dentistry ... found significant deficiencies in the company,s manufacturing processes that ...
Cached Medicine Technology:Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote 2Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote 3Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote 4U.S. Marshals Seize Dental Devices From Florida Manufacturer 2
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Alcon offers medical grade perfluoropropane (SF6) intraocular gases for ophthalmological use....
Silikon 1000 (purified polydimethylsiloxane) is a highly purified long chain polydimethylsiloxane trimethylsiloxy terminated silicone oil. For use as a postoperative retinal tamponade during vitreore...
Medicine Products: